Dwi U. Kemaladewi

1.1k citations

16 papers · 609 indexed · h-index 11

Co-authors: Peter A.C. ’t Hoen Willem M.H. Hoogaars Peter ten Dijke Ronald D. Cohn Annemieke Aartsma‐Rus Elzbieta Hyatt Evgueni A. Ivakine David J. J. de Gorter
Topics: Muscle Physiology and Disorders (7 papers)RNA Research and Splicing (4 papers)CRISPR and Genetic Engineering (3 papers)
Cited by: Aging Business and International Management Molecular Biology
Journals: Nature Nature Medicine PLoS ONE
Partner nations: Netherlands Canada United States

In The Last Decade

Dwi U. Kemaladewi

15 papers receiving 607 citations

Peers

Countries citing papers authored by Dwi U. Kemaladewi

Since Specialization

Citations

This map shows the geographic impact of Dwi U. Kemaladewi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dwi U. Kemaladewi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dwi U. Kemaladewi more than expected).

Fields of papers citing papers by Dwi U. Kemaladewi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dwi U. Kemaladewi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dwi U. Kemaladewi. The network helps show where Dwi U. Kemaladewi may publish in the future.

Co-authorship network of co-authors of Dwi U. Kemaladewi

This figure shows the co-authorship network connecting the top 25 collaborators of Dwi U. Kemaladewi. A scholar is included among the top collaborators of Dwi U. Kemaladewi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dwi U. Kemaladewi. Dwi U. Kemaladewi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Gene replacement therapy to restore polyamine metabolism in a Snyder-Robinson syndrome mouse model 2025 ·Methods in enzymology on CD-ROM/Methods in enzymology ·(unknown),(unknown),(unknown),Dwi U. Kemaladewi	0
2	Impaired polyamine metabolism causes behavioral and neuroanatomical defects in a mouse model of Snyder–Robinson syndrome 2024 ·Disease Models & Mechanisms ·(unknown),(unknown),(unknown),(unknown),(unknown),Jackson R. Foley,(unknown),Yijen Wu,Tracy Murray Stewart,Robert A. Casero,Hülya Bayır,Dwi U. Kemaladewi	8
3	A mutation-independent approach for muscular dystrophy via upregulation of a modifier gene 2019 ·Nature ·Dwi U. Kemaladewi,(unknown),Steven Erwood,(unknown),Kinga I. Gawlik,(unknown),Elzbieta Hyatt,(unknown),(unknown),Ryan M. Marks,Madeleine Durbeej,Steven A. Prescott,Evgueni A. Ivakine,Ronald D. Cohn	100
4	Expanding the Boundaries of RNA Sequencing as a Diagnostic Tool for Rare Mendelian Disease 2019 ·The American Journal of Human Genetics ·Hernán Gonorazky,Sergey Naumenko,Arun Ramani,Viswateja Nelakuditi,Pouria Mashouri,(unknown),(unknown),(unknown),(unknown),Mark A. Tarnopolsky,Katherine D. Mathews,Steven A. Moore,Andres Nascimiento Osorio,(unknown),Dwi U. Kemaladewi,Ronald D. Cohn,Michael Brudno,James J. Dowling	133
5	Increased polyamines as protective disease modifiers in congenital muscular dystrophy 2018 ·Human Molecular Genetics ·Dwi U. Kemaladewi,Joel S. Benjamin,Elzbieta Hyatt,Evgueni A. Ivakine,Ronald D. Cohn	12
6	Correction of a splicing defect in a mouse model of congenital muscular dystrophy type 1A using a homology-directed-repair-independent mechanism 2017 ·Nature Medicine ·Dwi U. Kemaladewi,(unknown),Elzbieta Hyatt,Huayun Hou,(unknown),(unknown),Xinyi Zhu,(unknown),(unknown),Amit G. Deshwar,Daniele Merico,Hui Xiong,Brendan J. Frey,Michael D. Wilson,Evgueni A. Ivakine,Ronald D. Cohn	61
7	CRISPR/Cas9-mediated exon inclusion in Lama2 gene alleviates dystrophic pathology in MDC1A mouse model 2016 ·Neuromuscular Disorders ·Dwi U. Kemaladewi,Elzbieta Hyatt,(unknown),Ronald D. Cohn	2
8	Spell Checking Nature: Versatility of CRISPR/Cas9 for Developing Treatments for Inherited Disorders 2015 ·The American Journal of Human Genetics ·(unknown),Dwi U. Kemaladewi,(unknown),(unknown),(unknown),Elzbieta Hyatt,(unknown),Sérgio L. Pereira,James Stavropoulos,Vincent Mouly,Kamel Mamchaoui,Francesco Muntoni,Thomas Voit,Hernán Gonorazky,James J. Dowling,Michael D. Wilson,Roberto Mendoza‐Londono,Evgueni A. Ivakine,Ronald D. Cohn	83
9	Novel Ex Vivo Culture Method for the Study of Dupuytren's Disease: Effects of TGFβ Type 1 Receptor Modulation by Antisense Oligonucleotides 2014 ·Molecular Therapy — Nucleic Acids ·Sofia Karkampouna,Boudewijn P. T. Kruithof,Peter Kloen,Miryam C. Obdeijn,(unknown),Hans J. Tanke,Dwi U. Kemaladewi,Willem M.H. Hoogaars,Peter A.C. ’t Hoen,Annemieke Aartsma‐Rus,Ian M. Clark,Peter ten Dijke,Marie‐José Goumans,Marianna Kruithof‐de Julio	18
10	Targeting TGF-β Signaling by Antisense Oligonucleotide-mediated Knockdown of TGF-β Type I Receptor 2014 ·Molecular Therapy — Nucleic Acids ·Dwi U. Kemaladewi,(unknown),(unknown),Sandra H. van Heiningen,Gert‐Jan B. van Ommen,Peter ten Dijke,Annemieke Aartsma‐Rus,Peter A.C. ’t Hoen,Willem M.H. Hoogaars	28
11	G.O.6 2014 ·Neuromuscular Disorders ·Grace Yoon,(unknown),Tara Paton,(unknown),Elzbieta Hyatt,(unknown),Dwi U. Kemaladewi,(unknown),(unknown),Cynthia Hawkins,Ronald D. Cohn	2
12	Antisense-Oligonucleotide Mediated Exon Skipping in Activin-Receptor-Like Kinase 2: Inhibiting the Receptor That Is Overactive in Fibrodysplasia Ossificans Progressiva 2013 ·PLoS ONE ·(unknown),Jie Cai,David J. J. de Gorter,Gonzalo Sánchez‐Duffhues,Dwi U. Kemaladewi,Willem M.H. Hoogaars,Annemieke Aartsma‐Rus,Peter A.C. ’t Hoen,Peter ten Dijke	35
13	Tgf-β Signaling In Duchenne Muscular Dystrophy 2012 ·Future Neurology ·Dwi U. Kemaladewi,Peter A.C. ’t Hoen,Peter ten Dijke,G J van Ommen,Willem M.H. Hoogaars	5
14	Dual exon skipping in myostatin and dystrophin for Duchenne muscular dystrophy 2011 ·BMC Medical Genomics ·Dwi U. Kemaladewi,Willem M.H. Hoogaars,Sandra H. van Heiningen,(unknown),David J. J. de Gorter,Johan T. den Dunnen,G.J.B. van Ommen,Annemieke Aartsma‐Rus,Peter ten Dijke,Peter A.C. ’t Hoen	36
15	Cell‐type specific regulation of myostatin signaling 2011 ·The FASEB Journal ·Dwi U. Kemaladewi,David J. J. de Gorter,Annemieke Aartsma‐Rus,(unknown),Peter ten Dijke,Peter A.C. ’t Hoen,Willem M.H. Hoogaars	56
16	BMP antagonists enhance myogenic differentiation and ameliorate the dystrophic phenotype in a DMD mouse model 2010 ·Neurobiology of Disease ·(unknown),Willem M.H. Hoogaars,David J. J. de Gorter,Sandra H. van Heiningen,Herbert Y. Lin,Charles C. Hong,Dwi U. Kemaladewi,Annemieke Aartsma‐Rus,Peter ten Dijke,Peter A.C. ’t Hoen	30

About Dwi U. Kemaladewi

Dwi U. Kemaladewi is a scholar working on Aging, Business and International Management and Developmental Biology, having authored 16 papers that have together received 609 indexed citations. Recurring topics across this work include Muscle Physiology and Disorders (7 papers), RNA Research and Splicing (4 papers) and CRISPR and Genetic Engineering (3 papers). The work is most often cited by research in Aging (33 citations), Business and International Management (16 citations) and Molecular Biology (515 citations). Dwi U. Kemaladewi has collaborated with scholars based in Netherlands, Canada and United States. Frequent co-authors include Peter A.C. ’t Hoen, Willem M.H. Hoogaars, Peter ten Dijke, Ronald D. Cohn, Annemieke Aartsma‐Rus, Elzbieta Hyatt, Evgueni A. Ivakine, David J. J. de Gorter, James J. Dowling and Hernán Gonorazky. Their work appears in journals such as Nature, Nature Medicine and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact